Endomag
Endomag®, now a Hologic company, believes everyone deserves a better standard of cancer care. Our unique magnetic localisation technologies, already used to treat over 600,000 patients globally, help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is.
As a global leader in women's health, Hologic® shares this commitment - developing breakthrough technologies that detect, diagnose, and treat breast cancer earlier, with greater quality and accuracy. Together, we are redefining what’s possible in breast care, delivering best-in-class solutions that put your patients first.
Learn more at: www.endomag.com or www.hologic.co.uk
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2026 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. See the list of sponsors.
